- Open Access
Parasite densities modulate susceptibility of mice to cerebral malaria during co-infection with Schistosoma japonicum and Plasmodium berghei
Malaria Journal volume 13, Article number: 116 (2014)
Malaria and schistosomiasis are endemic and co-exist in the same geographic areas, even co-infecting the same host. Previous studies have reported that concomitant infection with Schistosoma japonicum could offer protection against experimental cerebral malaria (ECM) in mice. This study was performed to evaluate whether alterations in parasite density could alter this protective effect.
Mice were inoculated with 100 or 200 S. japonicum cercariae followed by infection with high or low density of Plasmodium berghei ANKA strain eight weeks after the first infection. Then, parasitaemia, survival rate and blood–brain-barrier (BBB) damage were assessed. Interferon-gamma (IFN-γ), interleukin (IL)-4, IL-5, IL-13, IL-10, and TGF-β levels were determined in splenocyte supernatants using enzyme-linked immunosorbent assay (ELISA). Cell surface/intracellular staining and flow cytometry were used to analyse the level of CD4+/CD8+ T cells, CD4+CD25+Foxp3+ Tregs, IL-10-secreting Tregs, and IL-10+Foxp3-CD4+ T cells in the spleen, and CD4+/CD8+ T cells infiltrating the brain.
Co-infection with low density P. berghei and increased S. japonicum cercariae significantly increased the levels of IL-4, IL-5, IL-13, TGF-β and Tregs, but significantly decreased the levels of IFN-γ and the percentage of CD4+ T cells and CD8+ T cells in the spleen and CD8+ T cell infiltration in the brain. Increased worm loads also significantly decreased mortality and BBB impairment during ECM. When challenged with higher numbers of P. berghei and increased cercariae, the observed cytokine changes were not statistically significant. The corresponding ECM mortality and BBB impairment also remained unchanged.
This study demonstrates that protection for ECM depends on the numbers of the parasites, S. japonicum and P. berghei, during co-infection. Alterations in the regulatory response appear to play a key role in this adaptation.
Malaria, caused by the infection of parasites belonging to Plasmodium species, is a major health problem for humans in many tropical regions of the world. This devastating disease kills more than one million children each year. Specifically, cerebral malaria (CM) is one of the most severe complications of Plasmodium infection and a major cause of death among young children in sub-Saharan Africa. Precise mechanisms of CM onset are still incompletely understood as multiple factors including both host and pathogen determinants are involved in the pathogenesis. Overall, it is considered that the sequestration of parasitized red blood cells (pRBCs) in cerebral microvasculature contributes to vessel occlusion, hypoxia, endothelial activation and blood–brain-barrier (BBB) dysfunction[4–6].
A number of studies have documented that CM results from a predominant Th1 response. Besides, a number of pro-inflammatory cytokines, including IFN-γ and relatively lower levels of anti-inflammatory cytokines, such as IL-10 were recorded in individuals with severe malaria[7, 8]. It is generally considered that a proper balance between pro- and anti-inflammatory molecules is essential to control the pathogenesis of severe malaria. While lack of an initial inflammatory stage may lead to increased parasite proliferation, an uncontrolled inflammatory response may lead to severe immunopathology. In this molecular balance, CD4+CD25+Foxp3+ regulatory T cells (Tregs) play a critical role. A previous report demonstrated that Tregs are required to limit pro-inflammatory immune responses in BALB/c mice to prevent experimental cerebral malaria (ECM) during secondary infections. It has also been confirmed that the occurrence of Tregs during Plasmodium berghei ANKA infection is negatively associated with the production of IFN-γ. Induced and/or activated Tregs may be beneficial to the vertebrate host because it down-regulates the inflammatory response and thereby prevents immune-mediated pathology.
Since helminths and malarial parasites share the same geographical distribution, they are known to infect the same vertebrate host population. Therefore, it is important to elucidate the immune mechanisms underlying the co-infection of these parasites. Both malaria and helminthiasis induce strong immune responses affecting the Th1/Th2 balance[13, 14]. In a previous study, it was documented that pre-existing Schistosoma japonicum infection strengthened the Tregs-associated Th2 response to malaria infection and this Th2 response played an important role in protecting against ECM pathology. The current study was designed to evaluate whether parasite density during co-infections modulated this protective effect that may reveal a parasite threshold for causing ECM.
All experimental protocols in the current study were reviewed and approved by the Medical University Institute of Medical Research Animal Ethics Committee in China.
Mice, parasites and experimental infection
Female C57BL/6 mice (four weeks old) were purchased from Beijing Animal Institute (Beijing, China) and maintained in individual ventilated cages in the animal facility at China Medical University. Mice were provided heat-sterilized food and distilled water ad libitum. C57BL/6 mice were selected as models in the current study because they showed high susceptibility to ECM due to their pro-inflammatory/Th1 predisposition.
The S. japonicum strain was obtained from Jiangsu Institute of Parasitic Diseases (Wuxi, China). Plasmodium berghei ANKA strain (clone 1.49 L) was provided by Dr. Motomi Torii at the Department of Molecular Parasitology, Ehime University Graduate School of Medicine, Ehime, Japan. Parasite stabilates were stored at -80°C. To obtain experimental inoculum of P. berghei, parasitized red blood cells (pRBCs) were sequentially passed through three homologous donor mice.
Infections were initiated in mice that were five weeks old. First, mice were infected percutaneously with 100 or 200 S. japonicum cercariae and eight weeks later mice in both groups were infected with higher dose (1 × 106) or lower dose (1 × 105) of P. berghei pRBCs. Control mice were infected with only P. berghei pRBCs or S. japonicum cercariae. Each group had 40 mice. The animals were euthanized one, three, five and eight days post-P. berghei infection for evaluation.
Confirmation of helminth infection
Helminth infection was confirmed by the presence of worms and liver granulomas upon necropsy. Worms were obtained by portal perfusion as described previously, and livers were examined for the presence of granulomas under a stereomicroscope.
Malaria parasitaemia, survival rates and disease assessment
Parasitaemia was determined by staining thin blood smears from mice tails with Giemsa and observation under light microscopy. Slides were coded and pRBCs were counted microscopically in at least five microscopic fields, each containing approximately 300 cells.
Every day post-P. berghei infection, mice were monitored for mortality. Clinical ECM was also assessed and was confirmed if at least four of the following signs were observed: ruffled fur, hunching, wobbly gait, limb paralysis, convulsions, or coma. Each sign was given a score of 1. Animals with scores ≥4 were considered to have severe ECM.
Spleen cell culture
Spleen cell culture was prepared as previously described[12, 17]. Briefly, spleens from infected mice were aseptically removed and pressed individually through a sterile fine-wire mesh along with 10 ml RPMI-1640 (Life Technologies, Shanghai, China) supplemented with 5% heat-inactivated fetal calf serum (FCS; Hyclone Laboratories, Inc., South Logan, Utah, USA), 25 mM Hepes (Life Technologies), 0.12% gentamicin (Schering-Plough, Kenny Worth, New Jersey, USA), and 2 mM glutamine (Life Technologies). Cell suspensions were centrifuged at 350 g for 10 min at room temperature (RT). Erythrocytes were lysed in cold 0.17 M NH4Cl and the cells were washed twice in fresh medium. Viability of the spleen cells was determined by trypan blue exclusion assay, which revealed >90% cell survival. Spleen cells were adjusted to a final concentration of 107 cells/ml in RPMI-1640 supplemented with 10% heat-inactivated FCS. Aliquots (500 μl/well) of the cell suspension were incubated in 24-well flat bottom culture plates (Falcon®, Corning Life Sciences, CA, USA) in triplicate for 48 hrs at 37°C in a humidified incubator with 5% CO2. The plates were then centrifuged at 350 g for 10 min at RT and the supernatants were collected and stored at -80°C until assayed for cytokine levels.
The levels of cytokines such as IFN-γ, IL-4, IL-5, IL-13, IL-10, and TGF-β in the splenocyte supernatants from infected mice were measured using commercial enzyme-linked immunosorbent assay (ELISA) kits according to the manufacturer’s instructions (R&D Systems, Minneapolis, MN, USA). All assays were performed in a microtitre plate reader and the absorbance was recorded at 450 nm. Cytokine concentrations in samples were calculated based on standard curves generated using recombinant cytokines.
Cell surface/intracytoplasmic staining and flow cytometry
From each experimental group, five or six mice were sacrificed at the indicated time points for flow cytometry. Spleen cells were collected from C57BL/6 mice post infection (pi). Cell concentration was then adjusted to 2 × 106/ml, followed by stimulation with plate-bound anti-mouse CD3 (1 μg/ml) and anti-mouse CD28 (0.2 μg/ml) together with Golgi Stop (BD Bioscience, Cat no 554724) for 4 hrs. After continued co-culture at 37°C for 4 hrs, cells were washed with 3% FCS and resuspended in 100 μl of 3% FCS followed by incubation with APC-conjugated anti-mouse-CD3, FITC-conjugated anti-mouse CD4, PerCP-Cy5.5-conjugated anti-mouse CD8 or PerCP-Cy5.5-conjugated anti-mouse CD25 (clone 3C7) for surface staining. The cells were then fixed, permeabilized and intracytoplasmic staining was performed using APC-conjugated anti-Foxp3 (clone FJK16s) or PE-conjugated anti-IL-10 (clone JES5-16E3). FITC-conjugated rat IgG2b was used as the isotype control.
To determine the migration of CD4+ and CD8+ T cells into the brain, mononuclear cells were isolated from the brains on day 6 pi. A single-cell suspension was obtained by homogenizing the tissues in 5 ml of RPMI 1640 containing 100 U/ml IV collagenase (Invitrogen, USA), and incubating at 42°C for 45 min. Cells were centrifuged at 300 g for 10 min, resuspended in 30% Percoll in PBS (Sigma), layered on 70% Percoll, and centrifuged at 515 g for 30 min at RT. Cells at the interface were isolated, washed twice, resuspended in PBS, and labeled with the following antibodies: FITC-anti-CD4, PerCP-Cy5.5-anti-CD8 (clone 53–6.7), or APC-anti-CD3 (clone 145-2C11) by incubating at 4°C for 30 min. After washing twice in PBS, flow cytometric analysis was performed using a FACS Calibur, and data were analysed with the FlowJo software.
Assessment of BBB impairment
A 2% Evans blue dye was prepared with Evans blue powder (Sigma-Aldrich, St Louis, USA) and PBS, followed by filtration and sterilization. Mice were injected intravenously with 200 μl of 2% Evans blue on day 6 pi. The animals were then sacrificed 1 hr later and brains were isolated to evaluate vascular leakage of the dye into the brain parenchyma. After image documentation, brain tissues were weighed and placed in formamide for 48 hrs at 37°C to extract Evans blue. Aliquots (100 μl) of this solution were analysed on a microtitre plate. Absorbance was measured at 620 nm on an ELISA reader and compared to a standard curve. Concentration of Evans blue was expressed as μg Evans blue per gram brain tissue.
Data were analysed using Prism (GraphPad, La Jolla, CA, USA). Differences in survival was analysed using a Log-rank (Mantel-Cox) Test. Differences between multiple means were compared by one-way ANOVA, Tamhane’s T2 test or Bonferroni test when the variance was heterogeneous or homogeneous, respectively. All tests were considered significant when P < 0.05.
Schistosoma japonicum- mono-infection
All control mice infected with only 100 or 200 S. japonicum cercariae survived until day 75 post infection (> 10 weeks) after which they were sacrificed. Necropsy was performed and the results confirmed the existence of helminth infection in both groups. The levels of associated cytokines on day 56 (8 weeks) post infection indicated high Th1/Th2 levels just before the secondary infection with P. berghei (Figure 1). These results indicated that S. japonicum infection was in prime when secondary P. berghei infections were experimentally induced on week 8 post S. japonicum infection. In addition, previous studies confirmed that responses to Schistosoma infections were highly Th2 polarized following the onset of egg production around week 6. In the current study, S. japonicum infection on week 8 was primed for a Th2 response.
Plasmodium berghei- Schistosoma japonicum-co-infection
To evaluate the impact of parasite density in offering protection against the onset of ECM during co-infection, two schemes were included with two different densities of both parasites, S. japonicum and P. berghei. Because mice in the S. japonicum- mono-infected group received no additional treatment during the co-infection period, no changes were observed in the levels of the cytokines (data not shown).
Parasitaemia and survival rate
Malaria parasitaemia and mortality were monitored in mice in the co-infection-100c and co-infection-200c groups, and challenged with 1 × 106 P. berghei (Figure 2A) or by 1 × 105 P. berghei (Figure 2B). In general, all mice showed increasing parasitaemia during the course of P. berghei infection. Among the groups, increasing worm loads resulted in a higher level of parasitaemia on day 4 and 5 pi, or day 4 pi when challenged with higher or lower density of P. berghei, respectively. Between days 6 and 8, which is the period of susceptibility to ECM, most mice presented clinical signs of ECM and subsequently died. Mice in the co-infection-200c group showed a significantly higher survival rate than the co-infection-100c mice group, when challenged with low density of P. berghei. However, the difference was not significant when co-infected with a higher level of P. berghei.
To evaluate the relationship between the levels of pro- (IFN-γ) and anti-inflammatory (IL-4, IL-5, and IL-13) cytokines, and to assess cytokines involved in the regulatory responses (IL-10 and TGF-β) in the co-infected and P. berghei-mono-infected mice, cytokine levels in the supernatants of cultured splenocytes from mice in all groups were measured by ELISA. When infected with higher levels of P. berghei all cytokines including IFN-γ, IL-4, IL-5, IL-13, IL-10, and TGF-β increased immediately post-P. berghei infection, peaking on day 5 pi and then declining on day 8 pi (Figure 3A). Compared to P. berghei-mono, mice in the co-infection-100c group had significantly lower levels of IFN-γ on days 5 and 8 pi and higher levels of IL-4, IL-5, IL-13 and TGF-β on days 3, 5, and 8 pi, while no significant changes in IL-10 levels were observed between the two groups. A comparison between the co-infection-200c and co-infection-100c mice showed no significant difference among all pro- and anti-inflammatory cytokines measured. When challenged with lower density of P. berghei, the changes in cytokine levels over time were similar to those infected with high density of P. berghei (Figure 3B). Besides, co-infected mice showed significantly lower levels of IFN-γ and higher levels of IL-4, IL-5, IL-13, and TGF-β when compared to mice in P. berghei-mono group. Between the co-infection-200c and co-infection-100c groups, these cytokine changes were significant.
The kinetics of T cells population assessed by flow cytometry revealed that both splenic CD4+ and CD8+ T cells expanded during the course of P. berghei infection (Figure 4). In the two different S. japonica schemes, mice in the co-infection-100c group had significantly lower levels of CD4+ and CD8+ T cells on days 3, 5 and 8 pi when compared to P. berghei-mono group. Interestingly, these differences were observed only when challenged with lower density of P. berghei when made comparisons between the co-infection-200c and co-infection-100c groups. The kinetics of Tregs in both experimental schemes was also evaluated (Figure 4). Both IL-10-secreting Tregs, and IL-10 producing Foxp3-CD4+ T cells increased when challenged with higher (Figure 4A) or lower (Figure 4B) levels of P. berghei, peaking on day 5 pi and declining on day 8 pi. Among the two experimental schemes, the co-infection-100c group showed significantly higher levels of Tregs on days 5 and 8 pi when compared to P. berghei-mono group. Between the co-infection-200c and co-infection-100c groups, a significant change in this cytokine was present only when challenged with lower levels of P. berghei. In both experiments, no significant changes were observed in IL-10-secreting-Tregs and IL-10+Foxp3-CD4+ T cells.
To determine whether parasite dosage affected the migration and accumulation of T cells in the brains of S. japonicum-P. berghei-co-infected mice, mononuclear cells were isolated from the brain followed by quantification of CD4+ (Figure 5A)and CD8+ (Figure 5B) T cells. Compared to P. berghei- mono-infected mice, those in the co-infection-100c group recorded a significantly lower CD8+ T cell accumulation when challenged with high or low density of P. berghei. In contrast, when compared between co-infection-200c and co-infection-100c mice, such significant change was present only when challenged with low density of P. berghei.
BBB damage assessment
One of the hallmarks of CM is the damage of BBB integrity, which was analysed in all experiments both qualitatively and quantitatively. When compared to P. berghei- mono-infected mice, those co-infected with higher or lower densities of P. berghei along with S. japonicum displayed weak staining. A representative result in Figure 5C shows brains of mice challenged with 1 × 106P. berghei ranging in color from dark blue, moderate blue, faint blue and unstained brain in P. berghei-mono, co-infection-100c, co-infection-200c, and normal control mice, respectively. In addition, colorimetric analysis of co-infected mice also showed significantly lower mass ratio of Evans blue/brain tissue than P. berghei- mono-infected mice. However, a comparison between co-infection-200c and co-infection-100c mice revealed that the significance was present only in those challenged with low density of P. berghei (Figure 5D).
Epidemiological studies on malaria and schistosomiasis suggest common immune responses to co-infections in people living in areas where these diseases are co-endemic. A previous study documented the existence of shared antigens in the pathogens and cross-reactive antibodies to different components of the two parasites. It is well known that Schistosoma infections have potent immunomodulatory effects on their hosts based on their anti-inflammatory effect, which dampens IFN-γ responses and switches immune responses toward a Th2 type response through Tregs. During the past decade, many studies examined the impact of malaria co-infection with schistosomiasis although the results were contradicting. In a Plasmodium yoelii murine model, co-existing Schistosoma mansoni infection appeared to increase parasitaemia and the lethal disease. Waknine-Grinberg et al. and Bucher et al. demonstrated that S. mansoni co-infected with P. berghei offered protection against cerebral malaria, while Lyke et al. and Thigpen et al. showed that Schistosoma haematobium infection decreased Tregs and Plasmodium parasitaemia, combined with increased IFN-γ and IL-2 during malaria infection. Thus, S. haematobium infection appears to increase the inflammatory response following malaria infection. Moreover, a study in Thailand documented that Plasmodium falciparum malaria increased in helminth-infected patients but reduced cerebral malaria and acute renal failure. These divergent results may be caused by the use of different Plasmodium strains co-infected with different Schistosoma strains, each in various quantities with different but overlapping influences on immunity.
Currently, S. mansoni is the most widely used Schistosoma species to evaluate host immune responses and only a few studies have used S. japonicum to create a Schistosoma-Plasmodium-co-infection murine model. A previous study demonstrated that S. japonicum co-infection could offer protection against cerebral malaria by enhancing Th2 responses. The current study further examined the interactions between S. japonicum and P. berghei when the worm loads and Plasmodium densities were changed by evaluating several critical factors, such as malaria parasitaemia, Th1/Th2 responses, and the regulatory responses.
Plasmodium parasitaemia could be affected by multiple factors, including the dose of parasites infecting a host, immunity status of the host, and additional antigen interference, such as concomitant infection with Schistosoma. In general, it is believed that concomitant infection with Schistosoma could increase Plasmodium parasitaemia, which is consistent with results from the current study. This study also indicated that increasing the cercariae load also increased the parasitaemia in co-infected mice. The likely cause for this is the enhanced Th2 response when increasing the worm load. The associated Th1/Th2 cytokine analysis in future investigations will offer additional insights into the regulation of this mechanism.
Previous reports have indicated the role of cytokines IFN-γ, IL-4, IL-5, and IL-13 in response to co-infections with Plasmodium and Schistosoma. Wang et al. also documented an increase in Th2 cytokines and decline in Th1 cytokines concomitant with S. japonicum infection. Existing evidence suggests that increased worm load could lead to a more polarized Th2 response during Schistosoma-Plasmodium- co-infection. Yet this occurred only when the density of Plasmodium was low suggesting that the previous speculation of the immunomodulatory mechanism may be an oversimplification and may not apply at least for co-infections with worms and malaria parasites. Immune response during co-infections is complex largely due to an interactive effect between the responses triggered by two parasites. Schistosoma infection could down-regulate Th1 responses induced by Plasmodium infection although this effect may be suppressed when Plasmodium-induced Th1 response is too strong, as evidence in this study in mice challenged with high density of P. berghei. Taken together, these findings indicate that increased worm loads may lead to a decrease in Th1 response with concomitant Plasmodium infection, while the reduction magnitude may depend on Plasmodium density.
Another hypothesis in the present study is that regulatory responses, including Tregs, IL-10 and TGF-β, play a role in the immune responses of the vertebrate host during co-infections. Previous studies have reported the involvement of Tregs in the immune responses to both malaria[11, 12] and schistosomiasis infections. In vitro culture experiments have suggested that IL-10 and TGF-β are major cytokines that drive the induction and expansion of Tregs. Results of the current study indicate that TGF-β plays a major role in the induction of Tregs mediated anti-inflammatory responses as evidenced by a significant increase in TGF-β levels in co-infected mice while the IL-10 levels remained unchanged. In general, Tregs is known to play two major roles in host immunity. First, Tregs could block T cell-mediated clearance of malaria parasites, facilitating an increase in parasitaemia. Second, Tregs could potentially play a beneficial role in preventing immunopathology during the infection. In a previous study, Ashraful et al. documented a Tregs-induced reduction in T cell-mediated parasite tissue sequestration in a mouse malaria model, thereby limiting malaria-induced immune pathology. The study reported that total depletion of natural Tregs could not offer protection against ECM. In contrast, sufficient expansion of Tregs via IL-2Jc during P. berghei infection could suppress normal pathogenic T cell responses and prevented ECM. Pre-existing S. japonicum infection has been also reported to increase the absolute number of Tregs in splenocytes. The findings of the current study corroborate these data and further extend the occurrence of increased Tregs numbers to increased worm loads during the co-infection with lower density P. berghei. This immune response could indeed offer more protection against ECM.
Based on previous pathophysiological manifestations, C57BL/6 mice animal models were highly susceptible to P. berghei infections. In this study, BBB impairment was chosen for analysis rather than brain histopathology because of the ease in visualizing cerebral damage by naked eyes without the need for microscopes or any other complicated instrumentation. In addition, quantitative analysis by colorimetric modality provided more precise evidence to evaluate ECM impairment. These results showed that increasing worm loads concomitant with low density of P. berghei resulted in higher protection against ECM. A previous study established that INF-γ was required for the development of ECM during P. berghei infection in C57BL/6 mice. Here, INF-γ-producing CD4+ T cells, but not innate or CD8+ T cells promoted the development of ECM. The cerebral pathology during ECM is an IFN-γ-dependent process as evidenced by the complete resistance of the IFN-γ deficient mice to ECM. IFN-γ is responsible for the induction of chemokines CXCL9 and CXCL10 during ECM, which subsequently recruit CD4+ and CD8+ T cells to the brain[32, 33], with the latter one worked as the key role for pathogenicity. The current study also showed the expansion of splenic CD4+ and CD8+ T cells during the course of P. berghei infection although the phenotypes of T cells infiltration in the brain differed between the co-infected and P. berghei-mono-infected mice; CD8+ T cells were lower in co-infected mice when compared to P. berghei- mono-infected mice, and increasing the worm load during the co-infection further turned down the levels of CD8+ T cells. These results were consistent with the associated ECM survival data.
Among the various studies performed to explore the immunomodulatory mechanisms during malaria co-infection, most have been on infections with different Schistosoma species and various Plasmodium species, which is similar to the current study but thus far none had addressed the effect of parasite densities during co-infection. Waknine-Grinberg et al. performed a study and showed that increased cercarial dose provided more protection against ECM, which is consistent with results from the current study. The regulatory responses and associated cytokines investigated in the current study offer more insights into the immune responses during such infections. This study clearly demonstrates that both the Schistosoma and Plasmodium densities play major roles in modulating the immune responses of the vertebrate host during co-infection. These findings offer useful insights to understand the complex array of immune responses to malaria co-infections in murine models that may explain why certain individuals develop CM while others exhibit only minor symptoms in human malaria infections.
The results of this study demonstrate that changes in parasite density, both worm loads and Plasmodium parasite count, could modulate protection against ECM during the S. japonicum-P. berghei-co-infection. Increased cercariae co-infected with low density of P. berghei resulted in higher protection against ECM, while co-infection with higher density of P. berghei led to a converse result. Alterations in the regulatory response appear to play a key role in this adaptation.
Experimental cerebral malaria
Parasitized red blood cells
Regulatory T cells.
Pierce SK, Miller LH: What malaria knows about the immune system that immunologists still do not?. J Immunol. 2009, 182: 5171-5177. 10.4049/jimmunol.0804153.
Shan Y, Liu J, Pan YY, Jiang YJ, Shang H, Cao YM: Age-related CD4(+)CD25(+)Foxp3(+) regulatory T-cell responses during Plasmodium berghei ANKA infection in mice susceptible or resistant to cerebral malaria. Korean J Parasitol. 2013, 51: 289-295. 10.3347/kjp.2013.51.3.289.
Schmidt KE, Schumak B, Specht S, Dubben B, Limmer A, Hoerauf A: Induction of pro-inflammatory mediators in Plasmodium berghei infected BALB/c mice breaks blood–brain-barrier and leads to cerebral malaria in an IL-12 dependent manner. Microbes Infect. 2011, 13: 828-836. 10.1016/j.micinf.2011.04.006.
Conroy AL, Glover SJ, Hawkes M, Erdman LK, Seydel KB, Taylor TE, Molyneux ME, Kain KC: Angiopoietin-2-levels are associated with retinopathy and predict mortality in Malawian children with cerebral malaria: a retrospective case–control study. Crit Care Med. 2012, 40: 952-959. 10.1097/CCM.0b013e3182373157.
Beare NA, Harding SP, Taylor TE, Lewallen S, Molyneux ME: Perfusion abnormalities in children with cerebral malaria and malarial retinopathy. J Infect Dis. 2009, 199: 263-271. 10.1086/595735.
Kim H, Erdman LK, Lu Z, Serghides L, Zhong K, Dhabangi A, Musoke C, Gerard C, Cserti-Gazdewich C, Liles WC, Kain KC: Functional roles for C5a and C5Ar, but not C5l2, in the pathogenesis of human and experimental cerebral malaria. Infect Immun. 2014, 82: 371-379. 10.1128/IAI.01246-13.
McCall MB, Sauerwein RW: Interferon-γ–central mediator of protective immune responses against the pre-erythrocytic and blood stage of malaria. J Leukoc Biol. 2010, 88: 1131-1143. 10.1189/jlb.0310137.
Clark IA, Budd AC, Alleva LM, Cowden WB: Human malarial disease: a consequence of inflammatory cytokine release. Malar J. 2006, 5: 85-10.1186/1475-2875-5-85.
Bucher K, Dietz K, Lackner P, Pasche B, Fendel R, Mordmüller B, Ben-Smith A, Hoffmann WH: Schistosoma co-infection protects against brain pathology but does not prevent severe disease and death in a murine model of cerebral malaria. Int J Parasitol. 2011, 41: 21-31. 10.1016/j.ijpara.2010.06.008.
Frosch AE, John CC: Immunomodulation in Plasmodium falciparum malaria: experiments in nature and their conflicting implications for potential therapeutic agents. Expert Rev Anti Infect Ther. 2012, 10: 1343-1356. 10.1586/eri.12.118.
Nie CQ, Bernard NJ, Schofield L, Hansen DS: CD4 + CD25+ regulatory T cells suppress CD4+ T-cell function and inhibit the development of Plasmodium berghei-specific TH1 responses involved in cerebral malaria pathogenesis. Infect Immun. 2007, 75: 2275-2282. 10.1128/IAI.01783-06.
Wu JJ, Chen G, Liu J, Wang T, Zheng W, Cao YM: Natural regulatory T cells mediate the development of cerebral malaria by modifying the pro-inflammatory response. Parasitol Int. 2010, 59: 232-241. 10.1016/j.parint.2010.02.007.
Adegnika AA, Kremsner PG: Epidemiology of malaria and helminth interaction: a review from 2001 to 2011. Curr Opin HIV AIDS. 2012, 7: 221-224. 10.1097/COH.0b013e3283524d90.
Hartgers FC, Obeng BB, Kruize YC, Dijkhuis A, McCall M, Sauerwein RW, Luty AJ, Boakye DA, Yazdanbakhsh M: Responses to malarial antigens are altered in helminth-infected children. J Infect Dis. 2009, 199: 1528-1535. 10.1086/598687.
Wang ML, Cao YM, Luo EJ, Zhang Y, Guo YJ: Pre-existing Schistosoma japonicum infection alters the immune response to Plasmodium berghei infection in C57BL/6 mice. Malar J. 2013, 12: 322-10.1186/1475-2875-12-322.
Smithers SR, Terry RJ: The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of the adult worms. Parasitology. 1965, 55: 695-700.
Ma SH, Zheng L, Liu YJ, Guo SY, Feng H, Chen G, Li DM, Wang JC, Cao YM: Plasmodium yoelii: influence of antimalarial treatment on acquisition of immunity in BALB/c and DAB/2 mice. Exp Parasitol. 2007, 116: 266-272. 10.1016/j.exppara.2007.01.007.
Pearce EJ, MacDonald AS: The immunobiology of schistosomiasis. Nat Rev Immunol. 2002, 2: 499-511. 10.1038/nri843.
Troye-Blomberg M, Berzins K: Immune interactions in malaria co-infections with other endemic infectious disease: implications for the development of improved disease interventions. Microbes Infect. 2008, 10: 948-952. 10.1016/j.micinf.2008.07.014.
Pierrot C, Wilson S, Lallet H, Lafitte S, Jones FM, Daher W, Capron M, Dunne DW, Khalife J: Identification of a novel antigen of Schistosoma mansoni shared with Plasmodium falciparum and evaluation of different cross-reactive antibody subclasses induced by human schistosomiasis and malaria. Infect Immun. 2006, 74: 3347-3354. 10.1128/IAI.01724-05.
Sangweme D, Shiff C, Kumar N: Plasmodium yoelii: adverse outcome of no-lethal P. yoelii malaria during co-infection with Schistosoma mansoni in BALB/c mouse model. Exp Parasitol. 2009, 122: 254-259. 10.1016/j.exppara.2009.04.003.
Waknine-Grinberg JH, Gold D, Ohayon A, Flescher E, Heyfets A, Doenhoff MJ, Schramm G, Haas H, Golenser J: Schistosoma mansoni infection reduces the incidence of murine cerebral malaria. Malar J. 2010, 9: 5-10.1186/1475-2875-9-5.
Lyke KE, Dabo A, Arama C, Daou M, Diarra I, Wang A, Plowe CV, Doumbo OK, Sztein MB: Reduced T regulatory cell response during acute Plasmodium falciparum infection in malian children co-infected with Schistosoma haematobium. PLoS ONE. 2012, 7: e31647-10.1371/journal.pone.0031647.
Thigpen MC, Filler SJ, Kazembe PN, Parise ME, Macheso A, Campbell CH, Newman RD, Steketee RW, Hamel M: Associations between peripheral Plasmodium falciparum malaria parasitemia, human immunodeficiency virus, and concurrent helminthic infection among pregnant women in Malawi. Am J Trop Med Hyg. 2011, 84: 379-385. 10.4269/ajtmh.2011.10-0186.
Nacher M: Worms and malaria: blind men feeling the elephant?. Parasitology. 2008, 135: 861-868.
Wilson MS, Mentink-Kane MM, Pesce JT, Ramalingam TR, Thompson R, Wynn TA: Immunopathology of schistosomiasis. Immunol Cell Biol. 2007, 85: 148-154. 10.1038/sj.icb.7100014.
Dunne DW, Cooke A: A worm’s eye of the immune system: consequences for evolution of human autoimmune disease. Nat Rev Immunol. 2005, 5: 420-426. 10.1038/nri1601.
Scholzen A, Mittag D, Rogerson SJ, Cooke BM, Plebanski M: Plasmodium falciparum- mediated induction of human CD25FoxP3 CD4 T cells is independent of direct TCR stimulation and requires IL-2, IL-10 and TGFbeta. PLoS Pathog. 2009, 5: e1000543-10.1371/journal.ppat.1000543.
Haque A, Best SE, Amante FH, Mustafah S, Desbarrieres L, de Labastida F, Sparwasser T, Hill GR, Engwerda CR: CD4+ natural regulatory T cells prevent experimental cerebral malaria via CTLA-4 when expanded in vivo. PloS Pathog. 2010, 6: e1001221-10.1371/journal.ppat.1001221.
Amani V, Vigario AM, Belnoue E, Marussig M, Fonseca L, Mazier D, Renia L: Involvement of IFN-gamma receptor-medicated signaling in pathology and anti-malarial immunity induced by Plasmodium berghei infection. EurJ Immunol. 2000, 30: 1646-1655. 10.1002/1521-4141(200006)30:6<1646::AID-IMMU1646>3.0.CO;2-0.
Carter SL, Muller M, Manders PM, Campbell IL: Induction of the genes for Cxcl9 and Cxcl10 is dependent on IFN-gamma but shows differential cellular expression in experimental autoimmune encephalomyelitis and by astrocytes and microglia in vitro. Glia. 2007, 55: 1728-1739. 10.1002/glia.20587.
Belnoue E, Potter SM, Rosa DS, Mauduit M, Gruner AC, Kayibanda M, Mitchell AJ, Hunt NH, Renia L: Control of pathogenic CD8+ T cell migration to the brain by IFN-gamma during experimental cerebral malaria. Parasite Immunol. 2008, 30: 544-553. 10.1111/j.1365-3024.2008.01053.x.
Belnoue E, Kayibanda M, Vigario AM, Deschemin JC, van Rooijen N, Viguier M, Snounou G, Renia L: On the pathogenic role of brain-sequestered alphabeta CD8+ T cells in experimental cerebral malaria. J Immunol. 2002, 169: 6369-6375.
Deepest thanks to Dr. Motomi Torii (Ehime University Graduate School of Medicine, Ehime, Japan) for providing malarial parasite strains of P. berghei ANKA. We also thank Jiangsu Institute of Parasitic Diseases (Wuxi, China) for providing S. japonicum parasites. Y-mC was supported by a grant from the Research Found for the Doctoral Programme of Higher Education of China (No. 20112104110018). M-lW was supported by grant from a scientific research project (No. L2012287) sponsored by the Education Department of Liaoning Province, China, grant from Natural Science Foundation of Liaoning Province (No. 2013021010).
The authors declare that they have no competing interests.
All of the authors collaborated on the work presented in this study. M-lW, Y-mC and E-jL defined the research theme; M-lW prepared the infected animal models, designed the methods, performed parts of the experiments, and interpreted the results; WP, Y-hF and Z-mQ performed some of the experiments; YZ and Y-jG analysed the data; and M-lW, YZ, E-jL, and Y-mC drafted the manuscript. All authors read and approved the final version of the manuscript.
About this article
Cite this article
Wang, M., Feng, Y., Pang, W. et al. Parasite densities modulate susceptibility of mice to cerebral malaria during co-infection with Schistosoma japonicum and Plasmodium berghei. Malar J 13, 116 (2014). https://0-doi-org.brum.beds.ac.uk/10.1186/1475-2875-13-116
- Plasmodium berghei ANKA
- Schistosoma japonicum
- Inflammatory cytokine
- Parasite density